ARPINATI, MARIO
ARPINATI, MARIO
Alma Mater Studiorum Universita' di Bologna
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
2004 ARPINATI M; CHIRUMBOLO G; URBINI B; BONIFAZI F; BANDINI G; SAUNTHARARAJAH Y; ZAGNOLI A; STANZANI M; FALCIONI S; PERRONE G; TURA S; BACCARANI M.; RONDELLI D.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment
2022 Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V.; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C.
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement
2021 Cristiano G.; Nanni J.; Sartor C.; Parisi S.; Marconi G.; Barbato F.; Arpinati M.; Bonifazi F.; Curti A.; Cavo M.; Paolini S.; Papayannidis C.
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study.
2019 Chiereghin A, Piccirilli G, Belotti T, Prete A, Bertuzzi C, Gibertoni D, Gabrielli L, Turello G, Borgatti EC, Barbato F, Sessa M, Arpinati M, Bonifazi F, Lazzarotto T.
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
2007 Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Borrelli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M.
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT).
2007 Arpinati M.; Versura P.; Profazio V.; Giannini M.B.; Bonifazi F.; Bandini G.; Stanzani M.; Giovannini M.; Campos E.C.; Baccarani M.
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
2020 Bonifazi F.; Barbato F.; Ravaioli F.; Sessa M.; Defrancesco I.; Arpinati M.; Cavo M.; Colecchia A.
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation
2016 Giannaccare, Giuseppe; Bonifazi, Francesca; Sessa, Mariarosaria; Fresina, Michela; Arpinati, Mario; Bandini, Giuseppe; Versura, Piera
Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye
2013 VERSURA P; PROFAZIO V; BUZZI M; STANCARI A; ARPINATI M; MALAVOLTA N; CAMPOS EC
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease
2019 Giannaccare, Giuseppe*; Bernabei, Federico; Pellegrini, Marco; Arpinati, Mario; Bonifazi, Francesca; Sessa, Mariarosaria; Versura, Piera; Campos, Emilio
Follicle features in adolescent and young adult women with Hodgkin's disease prior to chemotherapy: a preliminary report.
2011 Fabbri R;Pasquinelli G;Magnani V;Arpinati M;Battaglia C;Paradisi R;Venturoli S
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients.
2012 Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati M; Bandini G.
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
2007 Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Rondelli D.
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
2005 Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; Basi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M.
In vitro growth and differentiation of human dental pulp derived multipotent mesenchymal stem cells.
2004 Alviano F.; Pierdomenico L.; Fossati V.; Marchionni C.; Arpinati M.; Chirumbolo G.; Becchetti E.; Calvitti M.; Bonsi L.; Bagnara GP.
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
2005 BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M.
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation
2021 Pellegrini M.; Bernabei F.; Barbato F.; Arpinati M.; Giannaccare G.; Versura P.; Bonifazi F.
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
2008 Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D.
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant
2021 Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nanni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F.
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis
2012 F. Bonifazi; G. Bandini; M. Arpinati; G. Tolomelli; M. Stanzani; M. R. Motta; S. Rizzi; V. Giudice; E. Dan; E. Massari; P. Tazzari; A. Bontadini; P. Pagliaro; M. Baccarani
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. | ARPINATI M; CHIRUMBOLO G; URBINI B; BONIFAZI F; BANDINI G; SAUNTHARARAJAH Y; ZAGNOLI A; STANZANI ...M; FALCIONI S; PERRONE G; TURA S; BACCARANI M.; RONDELLI D. | 2004-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment | Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V....; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement | Cristiano G.; Nanni J.; Sartor C.; Parisi S.; Marconi G.; Barbato F.; Arpinati M.; Bonifazi F.; C...urti A.; Cavo M.; Paolini S.; Papayannidis C. | 2021-01-01 | ACTA HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. |
Chiereghin A, Piccirilli G, Belotti T, Prete A, Bertuzzi C, Gibertoni D, Gabrielli L, Turello G,... Borgatti EC, Barbato F, Sessa M, Arpinati M, Bonifazi F, Lazzarotto T. |
2019-01-01 | MEDICAL MICROBIOLOGY AND IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. |
Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Bor...relli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M. |
2007-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). | Arpinati M.; Versura P.; Profazio V.; Giannini M.B.; Bonifazi F.; Bandini G.; Stanzani M.; Giovan...nini M.; Campos E.C.; Baccarani M. | 2007-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation | Bonifazi F.; Barbato F.; Ravaioli F.; Sessa M.; Defrancesco I.; Arpinati M.; Cavo M.; Colecchia A. | 2020-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | fimmu-11-00489.pdf |
| Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation | Giannaccare, Giuseppe; Bonifazi, Francesca; Sessa, Mariarosaria; Fresina, Michela; Arpinati, Mari...o; Bandini, Giuseppe; Versura, Piera | 2016-01-01 | CORNEA | - | 1.01 Articolo in rivista | - |
| Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye | VERSURA P; PROFAZIO V; BUZZI M; STANCARI A; ARPINATI M; MALAVOLTA N; CAMPOS EC | 2013-01-01 | CORNEA | - | 1.01 Articolo in rivista | - |
| Eyelid metrics assessment in patients with chronic ocular graft versus-host disease | Giannaccare, Giuseppe*; Bernabei, Federico; Pellegrini, Marco; Arpinati, Mario; Bonifazi, Frances...ca; Sessa, Mariarosaria; Versura, Piera; Campos, Emilio | 2019-01-01 | THE OCULAR SURFACE | - | 1.01 Articolo in rivista | - |
| Follicle features in adolescent and young adult women with Hodgkin's disease prior to chemotherapy: a preliminary report. | Fabbri R;Pasquinelli G;Magnani V;Arpinati M;Battaglia C;Paradisi R;Venturoli S | 2011-01-01 | REPRODUCTIVE BIOMEDICINE ONLINE | - | 1.01 Articolo in rivista | - |
| Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. | Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati... M; Bandini G. | 2012-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. | Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Ronde...lli D. | 2007-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? | Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; B...asi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| In vitro growth and differentiation of human dental pulp derived multipotent mesenchymal stem cells. | Alviano F.; Pierdomenico L.; Fossati V.; Marchionni C.; Arpinati M.; Chirumbolo G.; Becchetti E.;... Calvitti M.; Bonsi L.; Bagnara GP. | 2004-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. | BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M. | 2005-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation | Pellegrini M.; Bernabei F.; Barbato F.; Arpinati M.; Giannaccare G.; Versura P.; Bonifazi F. | 2021-01-01 | AMERICAN JOURNAL OF OPHTHALMOLOGY | - | 1.01 Articolo in rivista | - |
| Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. | Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D. | 2008-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant | Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nan...ni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F. | 2021-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis | F. Bonifazi; G. Bandini; M. Arpinati; G. Tolomelli; M. Stanzani; M. R. Motta; S. Rizzi; V. Giudic...e; E. Dan; E. Massari; P. Tazzari; A. Bontadini; P. Pagliaro; M. Baccarani | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |